Skip to main content
Caplight Logo









Vesalio

Vesalio

Private
Plano, TexasHealthcare & Life Scienceshttps://www.vesalio.com/

Last Round

Series A

May 18, 2022

Total Funding Raised

$5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Vesalio is a medical device company that develops and manufactures thrombectomy platforms for the removal of blood clots in the brain, heart, and peripheral anatomy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurothrombectomystroke interventionstent retrieverclot removalneurovascular deviceacute ischemic strokethrombectomymechanical thrombectomyrecanalizationneurointerventional surgerystroke center equipmentmedical device manufacturer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vesalio Comparables

Compare Vesalio with similar companies based on industry and business-model similarity.

Vesalio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RapidPulse
90%
Ceretrieve
89%
Acandis
88%

Vesalio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 18, 2022
Early FundingMay 14, 2019

Key People

Founding team and executive leadership

J.D. McCulloch

Chief Financial Officer

Executive Team

Vesalio Investors

Notable investors and investment history

Vesalio investors
InvestorRounds
Orlando Health VenturesSeries A
Solas BioVenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2026

    Grew 21% QoQ, from 52 to 63 employees.

  • Jun 23, 2026

    Grew 24% QoQ, from 50 to 62 employees.

Recent news

Latest coverage and updates

  • launchesAug 13, 2026

    Vesalio launched pVasc NET on Aug 13th '26.

  • attends_eventJul 21, 2026

    Vesalio will attend event European Society of Cardiology (ESC) Congress 2026 on Aug 28th '26.

  • attends_eventJul 21, 2026

    Vesalio attended event ESC Congress 2026 on Aug 29th '26.

  • hiresJul 14, 2026

    Vesalio, LLC. hired Greg Cook as chief commercial officer on Jul 14th '26.

Vesalio Filings

Explore SEC and related filing metadata, where available.

Vesalio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vesalio's valuation, stock price, and market status.

Is Vesalio a public or private company?

Vesalio is a private company.

What is the current stock price of Vesalio?

Vesalio is a private company with no public stock price. No recent secondary market data is available.

How much is Vesalio worth (valuation)?

Valuation information for Vesalio is not publicly available.

Can I buy Vesalio stock?

Vesalio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vesalio's last funding round?

Vesalio's most recent funding round was Series A on May 18, 2022.

Who are the main investors in Vesalio?

Key investors in Vesalio include Solas BioVentures.

Will Vesalio IPO soon?

No public IPO plans have been announced for Vesalio.

How can I track Vesalio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vesalio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPlano, Texas
Employee Range31
Year Founded2017
Last FundingMay 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?